AML-144 Uroporphyrinogen Decarboxylase (UROD) Is a Therapeutically Targetable Dependency in Acute Erythroid Leukemia
Jake D. Friske(St. Jude Children's Research Hospital), Ilaira Lacobucci(St. Jude Children's Research Hospital), Jon P. Connelly(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Yu Fukuda(St. Jude Children's Research Hospital), John D. Schuetz(St. Jude Children's Research Hospital), Jonathon Klein(St. Jude Children's Research Hospital), Emily A. Backhaus(St. Jude Children's Research Hospital), Francesca Benini(St. Jude Children's Research Hospital), Trevor Cunningham(St. Jude Children's Research Hospital), Prady Baviskar(St. Jude Children's Research Hospital), Jiyang Yu(St. Jude Children's Research Hospital), Shondra M. Pruett‐Miller(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
|The Lancet Oncology|2009|1k